Probiotic Complex Shows Potential Benefits for Dry Eye Disease in Clinical Trial
A recent randomized, double-blind trial published in Nature Health Sciences evaluated a specific probiotic blend for dry eye disease, showing improvements in tear stability.
Key points
- Randomized, double-blind trial tested LB-101 probiotic complex in 80 adults with dry eye disease over eight weeks.
- Participants taking the probiotic showed a significant improvement in tear break-up time compared to the placebo group.
- Total OSDI scores and most objective surface endpoints showed no significant differences between groups.
Evaluating a Probiotic Approach for Ocular Health
Researchers at institutions including Samsung Medical Center and Kyung Hee University in Seoul investigated the effects of a probiotic complex, designated as LB-101 and containing Lactiplantibacillus plantarum NK151 and Bifidobacterium bifidum NK175, on adults suffering from dry eye disease (DED). The randomized, double-blind, placebo-controlled study enrolled 80 participants who received either the probiotic formulation or a placebo daily for eight weeks. Out of the initial group, 62 participants successfully completed the trial and were included in the final efficacy assessment.
Tear Stability Improvements and Symptom Measures
The trial found that individuals taking the LB-101 supplement experienced a statistically significant enhancement in tear break-up time compared to those in the placebo group, with a mean difference of 1.01 seconds. Furthermore, researchers noted notable improvements in specific individual symptom items measured by the Ocular Surface Disease Index (OSDI). However, the total OSDI scores and the majority of other objective ocular surface endpoints did not show significant differences between the two study arms. Exploratory analyses of the gut microbiota indicated an increase in Carnobacteriaceae and a reduction in endotoxin-producing Oxalobacteraceae among participants in the probiotic group, with no serious adverse events reported during the intervention period.
What to know: While the findings suggest that modulating the gut-eye axis may help improve tear film stability, the total symptom scores and most objective measures remained unchanged. Always consult a qualified physician before making decisions regarding dietary supplements or managing chronic health conditions.
Source Nature Health Sciences — nature.com/articles/s41598-026-79278-4 ↗
Read next
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🧠Mind & Mental HealthThe Role of Daily Mobility Training in Managing Sedentary Tension
A two-week personal trial suggests that incorporating short, daily mobility exercises may help alleviate stiffness associated with sedentary desk work. Experts note that …